Veeva Systems Class A (VEEV) closed at $301.53 on November 13, 2026, down 0.3% from the previous close, on volume of 708,700 shares (30-day average 1,382,397).
Data as of November 13, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 15, 2026 | Put Spread | 15-Jan-27250 : 280 P | 258 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days
RBC Capital Reaffirms Their Buy Rating on Veeva Systems (VEEV)
TipRanks (Thu, 12-Nov 8:55 PM ET)
Veeva to Release Fiscal 2027 Third Quarter Results on December 3, 2026
PRNewswire (Thu, 12-Nov 4:05 PM ET)
TipRanks (Wed, 11-Nov 5:50 AM ET)
TipRanks (Wed, 11-Nov 4:20 AM ET)
PRNewswire (Wed, 4-Nov 7:03 AM ET)
iOnctura appoints Paul Sekhri as Chair of its Board of Directors
Globe Newswire (Thu, 15-Oct 3:30 AM ET)
Veeva to Host Virtual Investor Day on November 5, 2026
PRNewswire (Wed, 14-Oct 4:06 PM ET)
Market Chameleon (Tue, 13-Oct 4:19 AM ET)
IQVIA Selects Veeva Clinical Operations Applications
Business Wire (Tue, 13-Oct 7:03 AM ET)
Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and Quality
PRNewswire (Thu, 8-Oct 7:03 AM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of November 16, 2026, VEEV stock price climbed to $301.83 with 309,037 million shares trading.
VEEV has a beta of 0.97, meaning it tends to be less sensitive to market movements. VEEV has a correlation of 0.06 to the broad based SPY ETF.
VEEV has a market cap of $48.87 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $928 million in Revenue and $2.35 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.25.
In the last 3 years, VEEV traded as high as $325.99 and as low as $148.05.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
VEEV has underperformed the market in the last year with a price return of +3.5% while the SPY ETF gained +11.8%. However, in the short term, VEEV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +19.5% vs -4.2% return in SPY. But in the last 2 weeks, VEEV shares have been beat by the market, returning -3.6% compared to an SPY return of -1.6%.
VEEV support price is $295.47 and resistance is $307.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV shares will trade within this expected range on the day.